Biopharmaceutical company
Appears in 1 story
Developer of AK0406, pursuing parallel clinical development in Australia, China, and the US
Shanghai-based ArkBio won U.S. Food and Drug Administration (FDA) clearance to test its experimental flu prevention drug in a Phase II trial. The drug, AK0406, is a long-acting antiviral designed to prevent influenza for an extended period, not just treat it after infection.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
